Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleMethods/New Tools, Novel Tools and Methods

Silhouette-Length-Scaled Gait Parameters for Motor Functional Analysis in Mice and Rats

Ivanna K. Timotius, Sandra Moceri, Anne-Christine Plank, Johanna Habermeyer, Fabio Canneva, Jürgen Winkler, Jochen Klucken, Nicolas Casadei, Olaf Riess, Bjoern Eskofier and Stephan von Hörsten
eNeuro 11 October 2019, 6 (6) ENEURO.0100-19.2019; DOI: https://doi.org/10.1523/ENEURO.0100-19.2019
Ivanna K. Timotius
1Machine Learning and Data Analytics Lab, Department of Computer Science, Faculty of Engineering, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91052 Erlangen-Nürnberg, Germany
4Department of Electronics Engineering, Satya Wacana Christian University, Salatiga 50711, Indonesia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Moceri
2Department Experimental Therapy, University Hospital Erlangen (UKEr) and Preclinical Experimental Animal Center, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen-Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Christine Plank
2Department Experimental Therapy, University Hospital Erlangen (UKEr) and Preclinical Experimental Animal Center, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen-Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Habermeyer
2Department Experimental Therapy, University Hospital Erlangen (UKEr) and Preclinical Experimental Animal Center, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen-Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabio Canneva
2Department Experimental Therapy, University Hospital Erlangen (UKEr) and Preclinical Experimental Animal Center, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen-Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Winkler
3Department of Molecular Neurology, University Hospital Erlangen (UKEr), Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen-Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jochen Klucken
3Department of Molecular Neurology, University Hospital Erlangen (UKEr), Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen-Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Casadei
5Institute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olaf Riess
5Institute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bjoern Eskofier
1Machine Learning and Data Analytics Lab, Department of Computer Science, Faculty of Engineering, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91052 Erlangen-Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan von Hörsten
2Department Experimental Therapy, University Hospital Erlangen (UKEr) and Preclinical Experimental Animal Center, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen-Nürnberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephan von Hörsten
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Visual Abstract

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract

Gait analysis of transgenic mice and rats modeling human diseases often suffers from the condition that those models exhibit genotype-driven differences in body size, weight, and length. Thus, we hypothesized that scaling by the silhouette length improves the reliability of gait analysis allowing normalization for individual body size differences. Here, we computed video-derived silhouette length and area parameters from a standard markerless gait analysis system using image-processing techniques. By using length- and area-derived data along with body weight and age, we systematically scaled individual gait parameters. We compared these different scaling approaches and report here that normalization for silhouette length improves the validity and reliability of gait analysis in general. The application of this silhouette length scaling to transgenic Huntington disease mice and Parkinson´s disease rats identifies the remaining differences reflecting more reliable, body length-independent motor functional differences. Overall, this emphasizes the need for silhouette-length-based intra-assay scaling as an improved standard approach in rodent gait analysis.

  • CatWalk
  • gait
  • Huntington
  • normalization
  • Parkinson
  • scaling

Significance Statement

Body size corresponds to gait parameters in both human and rodents. Using image-processing approaches, we computed the silhouette length of the rodent and demonstrated that it is correlated to the stride length, body speed, and swing speed. Subsequently, as a proof of concept, we used the resulting silhouette length for the scaling/normalization of these gait parameters of two rodent models for neurodegenerative disorders, namely Parkinson’s disease-relevant rat model and Huntington disease-relevant mouse model. Genotype-related alterations for silhouette length, stride length, body speed, and swing speed became smaller by applying our body silhouette-length-based scaling. In general, this silhouette-length-based gait parameter scaling is necessary for gait analysis in rodents, especially in studies involving young rodents, in preclinical longitudinal studies, and in studies with genotype-related body size difference.

Introduction

Motor function analysis is essential for studies of disorders characterized by motor impairments, such as Parkinson’s disease (PD; Tolosa et al., 2006; Jankovic, 2008) and Huntington disease (HD; Roos, 2010). A video-based markerless gait analysis tool for rodents, namely the CatWalk XT system (Hamers et al., 2001, 2006; Noldus Information Technology b.v., 2012), has been used in some preclinical studies. The CatWalk system quantifies several gait parameters based on the footprints and the body silhouettes of animals walking on an illuminated walkway in a darkened room. To continuously improve the outcome of the CatWalk-derived data acquisition, we recently described methods for the characterization of swaying movement in PD-relevant mouse models (Timotius et al., 2018b,c).

Recent publications reveal the association of several factors on gait parameters, such as body size (Heglund et al., 1974; Taylor, 1978; Machado et al., 2015), sex (Datto et al., 2016), strain, and locomotion speed (Taylor, 1978; Webb et al., 2003; Koopmans et al., 2007; Neckel et al., 2013; Machado et al., 2015; Neckel, 2015). Although the body size of rodents might influence gait analysis, the scaling of these parameters is not yet common in rodent gait analysis. Most researchers use adult rodents, where the body size is relatively similar and stable, and/or compare their preclinical models with wild-type controls of the same age (Cao et al., 2008; Vandeputte et al., 2010; Wang et al., 2012; Casadei et al., 2014; Chen et al., 2014; Ishikawa et al., 2014; Jacobs et al., 2014; Salvi et al., 2014). However, such an approach will not correct for genotype-driven body size differences as characteristic of some transgenic (TG) rodent models of human disorders including but not limited to HD (von Hörsten et al., 2003; Clemensson et al., 2017) and PD (Kohl et al., 2016). Body size-related gait parameter scaling appeared in a very few research studies (e.g., body-weight-based scaling of stride length measured by CatWalk; Frahm et al., 2018 and body-weight-based scaling of gait parameters measured by LocoMouse; Machado et al., 2015). For the reason that in the human gait analysis, body-height- or leg-length-based scaling is recommended for several gait parameters (Hof, 1996), we hypothesized here that body length-based scaling is more reliable for gait parameter scaling of rodents compared with body-weight-based scaling.

Body length (nose-to-anus length or nose-to-tail-base length) calculation in rodents was applied in several research works, in most cases of which, however, for this purpose anesthesia had to be applied to standardize and to keep the rodent motionless (Novelli et al., 2007; Dunn and Bale, 2009; Chakraborty et al., 2017). Such anesthesia procedures might add a confounding factor to the study design of the experiment (Karwacki et al., 2001) and, therefore, if possible, should be avoided. Therefore, direct in vivo measurements of body-length-related parameters during the execution of gait testing would offer the advantage of recording both body-length-related measurements in a functional fashion as well as gait-specific parameters in the same run, enabling longitudinal normalization of data collected from rodents from a young age until advanced adulthood, as often desired while investigating animal models of progressive degenerative conditions.

Body-length-related parameter computation method in a with-marker gait analysis system cannot directly be applied to a markerless gait analysis system. As a markerless video-based gait analysis tool, the CatWalk system (Hamers et al., 2001, 2006; Noldus Information Technology b.v., 2012) provides silhouette information along with the gait parameters. The silhouette length is directly related to the body length of the rodent. Therefore, CatWalk gait parameter scaling can be performed based on the silhouette length. This silhouette-length-based scaling connects the footprint-based gait parameters with the recorded body silhouettes of the walking animal. Therefore, we here considered the following aims:

  • 1. To propose silhouette length and area computation methods based on image-processing techniques.

  • 2. To investigate the correlation between silhouette length and several gait parameters.

  • 3. To compare silhouette length and measure body length.

  • 4. To propose a gait parameter scaling method based on the silhouette length.

  • 5. To compare the silhouette-length-based scaling with the silhouette-area-, body-weight-, and age-based scaling.

  • 6. To apply these methods to a mouse model and a rat model of neurodegenerative disorders exemplifying two species models of disease and allowing more reliable identification of genotype-driven differences.

Here we report, that, even in wild-type mice and rats, the computed body silhouette length is correlated with the stride lengths and speed-related parameters, thus describing that body silhouette length and motor function are interconnected. In fact, silhouette-length-based scaling lowers this correlation. We deliver supportive data that this silhouette-length-based scaling on the stride lengths and speed-related parameters cannot be replaced by other normalization factors such as the silhouette area, body weight, or age. Finally, we demonstrate that gait parameter differences between genotypes across age are more reliably detected by the application of our scaling approach using silhouette length differences.

Materials and Methods

Subjects

The animals used for this study were male bacterial artificial chromosome (BAC) α-synuclein (α-Syn) TG rats (Nuber et al., 2013; Kohl et al., 2016; Moceri et al., 2018) as a PD-relevant TG model, and BAC of mutant HTT gene (BACHD) mice (Gray et al., 2008), backcrossed to C57BL/6N, as an HD-relevant transgenic model and their corresponding wild-type littermates. The numbers of animals involved in the study are given in Figure 1. Parts of the data were presented at the Measuring Behavior Conference 2018, Manchester, U.K. (Timotius et al., 2018d). Data acquisition for the BAC α-Syn transgenic rats was presented at the AD/PD Meeting 2018 (Moceri et al., 2018). Additionally, for the purpose of comparing the video-based measured silhouette length and the corresponding manually measured body length, 10 additional BAC α-Syn rats were used in this study.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Scheme of experimental design. Depicted images were captured from the CatWalk video recordings providing information about the body silhouette and paw positions. The timeline displays the number of rodents and run videos analyzed within a longitudinal, repeated experimental design spanning five age points for rats and three age points for mice.

The rodents were maintained under specific pathogen-free conditions with a 12 h light/dark cycle and food and water available ad libitum. All research and animal care procedures were performed in compliance with international animal welfare standards and approved by the district of Lower Franconia, Würzburg, Bavaria, Germany (RegUFr#55.2-2532-2-218/54-2532.1-49/12).

Study protocol and data acquisition

Data acquisition was performed using the CatWalk system (Hamers et al., 2001, 2006; Noldus Information Technology b.v., 2012), a markerless gait analysis tool equipped with an enclosed corridor on a glass floor. As an animal walks through the alley, its body silhouette and paw contact positions are recorded by a video camera positioned under the walkway at a sampling rate of 100 Hz. Figure 1 gives examples of images captured from the recorded video. Footprint positions are labeled automatically by the CatWalk software and revised manually by an experienced observer. Several gait parameters are then automatically calculated based on these labeled footprints.

During the data collection process, rodents were free to walk from one end to the opposite end of the alley with no need for physical restrictions or rewards. The walking speeds were 30.7 ± 6.7 cm/s for rats and 30.3 ± 7.7 cm/s for mice (mean ± SD). All runs were recorded in the dark at a minimum level of external disturbing factors. Data were acquired between their young and advanced age at five different age points for rats and three different age points for mice, over several acquisition days for each age point. The number of animals and runs for each age point is given in Figure 1. Intraindividual longitudinal data were collected from a subgroup of animals in each group, thus allowing further investigation of the effect of growth on the gait parameters. The minimum number of individual repeated measures across ages was 16 for rats and 9 for mice.

For the comparison of the different scaling methods, the body weight of wild-type rodents was measured at ±1 week from the CatWalk gait data acquisition. The number of rats with body weight information was 22, 27, 17, and 16 assessed at the ages of 10–12, 26–29, 55–56, and 62–63 weeks, respectively. In addition, the number of mice with body weight information was 13, 13, and 12 assessed at the age of 21, 32, and 46 weeks, respectively.

Manual measurement of the body length for the additional 10 BAC-α-Syn rats was performed on isoflurane anesthetized rats by a physically measurement of the nose to tail-base length. All measurements have been performed on the consecutive day after the recording of the CatWalk video files for in total 67 runs of these animals.

Based on human motor functional analysis studies (Hof, 1996), human gait parameters related to length, duration, frequency, speed/velocity, moment, energy, power, angular velocity, angular acceleration, as well as the moment of inertia should be scaled by the human leg length or height. Not all of these gait parameters are provided in the CatWalk rodent gait analysis system. Therefore, the following parameters, pg, were chosen from the CatWalk-derived parameters for this study:

  • 1. Stride lengths:

    • (a) Front-paw stride length (cm)

    • (b) Hind-paw stride length (cm)

  • 2. Parameters relating to duration:

    • (a) Front-paw stand time (s)

    • (b) Front-paw swing time (s)

    • (c) Front-paw step cycle (s)

    • (d) Hind-paw stand time (s)

    • (e) Hind-paw swing time (s)

    • (f) Hind-paw step cycle (s)

  • 3. Speed parameters:

    • (a) Body speed (cm/s)

    • (b) Front-paw swing speed (cm/s)

    • (c) Hind-paw swing speed (cm/s)

The parameters obtained from the left and right paws were averaged, with the exception of body speed, which was averaged over all four paws.

Silhouette length and silhouette area computation

The silhouette length and silhouette area were computed using Matlab R2015a (8.5.0.) based on the unlabeled video and its corresponding background image. Representative images are shown in Figure 2a–d. The silhouette length computation begins at the first image frame where all paws are detected on the walkway and ends at the image frame where the first paw disappears from the recording area. These start and end points are obtained based on the information given by the CatWalk run data. This run data provides information on the labeled paw positions in each frame. Given that fRH, fLH, fRF, and fLF are vectors containing the frame number in ascending order of video frames with detected right hind-paws, left hind-paws, right front-paws, and left front-paws, respectively, fRH(1) and fLH(1) refer to the first appearance of the corresponding paws and fRF(last) and fLF(last) refer to the last appearance of the corresponding paws. The start and end frames are therefore obtained as follows:Embedded Image (1) Embedded Image (2)

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Scheme of image-flow analysis. a–j, Images captured from the unlabeled CatWalk videos (a, b); background images (c, d); background subtraction results IFG (e, f); binary largest objects IR (g, h); silhouette length illustration (i, j): rat with a silhouette length of 23.9 cm and mouse with a silhouette length of 9 cm.

For each frame between the start (fstart) and end (fstop) points, the silhouette extraction and tail removal are depicted in Figure 3 and are explained as follows: background subtraction is performed in order to extract the rodent’s body [foreground (IFG)] from the background (IBG). The foreground IFG of each image frame IO is extracted by choosing the image pixels that have a pixel value difference more than a threshold Th = 10 in at least one of the color layers (IL,R, IL,G, or IL,B) compared with the background image IBG. The value of the threshold Th was chosen to avoid noise oversensitivity. Some examples of the resulting images after background subtraction are shown in Figure 2, e and f, as follows:Embedded Image (3) Embedded Image (4)

Morphological image opening (Gonzalez and Woods, 2008): removal of the tail part from the image is performed via morphological opening using a diamond structuring element (ISE). This diamond shape was chosen to best preserve the without tail body shape. The distance rd from the structuring element origin to the points of the diamond was adjusted to the tail size of the rodents, which are rd = 9 mm (corresponding to 9 pixels with image resolution, xmm and ymm, 1 mm/pixel) for rats and rd = 5 mm (corresponding to 7 pixels with image resolution, xmm and ymm, 0.7 mm/pixel) for mice.

Hole filling (Gonzalez and Woods, 2008): this operation fills any hole in the object of the image IT. The resulting image is denoted by IH.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Block diagram of the silhouette extraction, tail removal, and silhouette parameters.

Retaining the largest object: the largest object in the image is then the body silhouette. Examples from the resulting image IR are shown in Figure 2, g and h.

The length of the silhouette is then calculated by first detecting the positions of the leftmost and rightmost pixels of the body silhouette that is retained in IR, as follows: (x1, y1), (x2, y2). Then, the Euclidean distance between these two points is calculated as follows:Embedded Image (5)

The image resolution xmm and ymm is indicated by the exported CatWalk data. The subtraction of rd is performed since in most cases half of the structure element area ISE belongs to the tail area. Illustrations of the length are shown in Figure 2, i and j, where the image resolutions for these specific videos are 1 mm/pixel for the rats and 0.7 mm/pixel for the mice.

The area of the silhouette is calculated by counting the number of pixels in the silhouette that is retained in IR, followed by multiplying it with the image resolution xmm and ymm. It is noteworthy that the silhouette area can be calculated from the silhouette (blob) including the tail, IFG, or excluding the tail, IR, according to the application need. After the silhouette length and area are calculated for each frame, the silhouette length and area of the whole run video are finally determined by the maximum length and area values from all the calculated lengths and areas of the video frames. By doing this, a value of silhouette length and a value of silhouette area are specified for every run video.

For all animals, where body weight information (w) is additionally available, a body weight silhouette length index, IWSL, can also be calculated. As silhouette length is related to body length, this index resembles the body mass index (Novelli et al., 2007), as follows:Embedded Image (6)

Gait parameters scaling method

The gait parameters pg are scaled by dividing their values by the silhouette length as indicated in Equation 7. This yields the silhouette-length-scaled gait parameters Embedded Image , as follows:Embedded Image (7)

For the parameters related to speed, an additional scaling method is also tested. This additional scaling method is adapted from human gait analysis (Hof, 1996). It is given in Equation 8, where g is the acceleration of gravity (9.81 m/s2 on earth). This yields the silhouette-length-scaled gait parameters Embedded Image , as follows:Embedded Image (8)

For the comparison of the different scaling methods, the parameters pg were also scaled based on silhouette area (asil), w, and age (a). The scaling method was performed in the same way as in Equation 7, by simply replacing silhouette length with silhouette area, body weight, or age. This yields other variations of the scaled gait parameters Embedded Image , as follows:Embedded Image (9) Embedded Image (10) Embedded Image (11)

Code accessibility

The computer code for calculating the silhouette length (see Silhouette length and silhouette area computation) together with data from several examples are freely available on-line at https://github.com/mad-lab-fau/SilhouetteLength.

Analysis

Silhouette length values were computed for all runs or videos of each animal in accordance with the description in the section Silhouette length and silhouette area computation. The silhouette length, gait parameters, as well as the scaled gait parameters computed from all run videos were subsequently averaged for each animal. Gait parameter scaling was performed for all the parameters listed in the section Study protocol and data acquisition. Scaled parameters were calculated for each run and averaged for each animal. Sample Pearson correlation coefficient (Pearson, 1895) r, coefficient of determination r 2, and the p- value between the silhouette length and gait parameters were computed. The r and p values before and after scaling were compared. For all gait parameters showing higher p values (and lower r values) on their scaled version, a repeated-measures ANOVA was performed based on animals that were tested consecutively at all age points. This repeated-measures ANOVA was also performed on the silhouette parameters (length and area) to investigate age-related effects.

The computed silhouette length values were compared with the physically measured body length values. This comparison was performed in the small cohort of rats by observing the correlation and the difference between silhouette length and body length.

The comparison study among silhouette-length-, silhouette-area-, weight-, and age-based scaling was performed in accordance with the scaling method in Equation 7, by simply replacing silhouette length with silhouette area, body weight, or age, as shown in Equations 9–11. Then, we evaluated both the r and p values of the correlation between gait parameters and silhouette area/weight/age. The body-weight-based scaling was performed by using the animals with corresponding body weight information.

Genotype-related differences were investigated via mixed ANOVA (occasionally also called two-way repeated-measures ANOVA) and multiple comparison tests with Bonferroni correction in Matlab R2015a (version 8.5.0.). The p values with lower bound adjustments were used to detect the presence of significant differences and were reported by using heat maps (Timotius et al., 2018a, 2019).

Results

Silhouette length and silhouette-length-based gait parameter scaling in wild-type rodents

The scatter plots of several gait parameters as a function of silhouette length for rats and mice are depicted in Figure 4. The color in the scatter plots denotes the age of the animals, with young rodents showing smaller silhouette lengths compared with older ones. The correlation coefficients between the gait parameters and silhouette length are given in Table 1. No significant correlation with the silhouette length was shown for the gait parameters relating to duration. Significant correlations (p < 0.05) were observed between stride length and silhouette length in rats as well as mice. Significant correlations in rats were also shown between the parameters related to speed and silhouette length, whereas only moderate correlations were shown in mice.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Scatter plots for the correlation between nonscaled and scaled gait parameters with silhouette length in wild-type rodents. The numbers of animals and the number of run videos are given in Figure 1. The animal data are the averaging results from their respective CatWalk run data. r values, r 2 values, p values, and the regression line were calculated from the animal data.

View this table:
  • View inline
  • View popup
Table 1.

Sample Pearson correlation coefficients (r) and p values of the silhouette length and CatWalk gait parameters

The scaling approaches were performed for all parameters listed in the section Study protocol and data acquisition. For the stride lengths and the parameters relating to speed, the scaled parameters showed lower r values (and higher p values) compared with nonscaled parameters. The speed parameters, which were scaled using Equation 7, displayed lower correlation coefficients compared with the parameters scaled using Equation 8.

The relation between silhouette length and measured body length calculated from the small cohort of rats is depicted in Figure 5b. The body length was measured from the nose-tip to tail-base, as shown in Figure 5a. A significant correlation between silhouette length and body length was shown (p < 0.01). The mean ± SD of the absolute difference between silhouette length and body length |Δ| was 0.49 ± 0.39 cm.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

a, Diagram of body length (nose-tip to tail-base) measurement. b, Scatter plot for correlation between body length and silhouette length of the small cohort of rats.

The age analysis of wild-type animals using repeated-measure ANOVA is given in Table 2. This analysis was conducted for the gait parameters that show significant correlations in Table 1 and for the silhouette parameters. In rats, significant effects of age are shown for silhouette parameters and gait parameters, excluding the body speed. In mice, a significant effect of age was shown for silhouette parameters and swing speeds. All of the scaled gait parameters listed in Table 2 show higher p values compared with their corresponding nonscaled parameters.

View this table:
  • View inline
  • View popup
Table 2.

The effect of age on the silhouette and gait parameters: repeated-measures ANOVA (p values)

Silhouette area-, body-weight-, and age-based gait parameter scaling in wild-type rodents

As rodents grow, it is reasonable to expect that the body silhouette length, body silhouette area, and body weight also increase. Correspondingly, high correlation among them, as well as age, were found (Table 3). The relationship between body weight and silhouette length for rats and mice is also reported as the scatter plots shown in Figure 6.

View this table:
  • View inline
  • View popup
Table 3.

Correlation between silhouette length, silhouette area (with tail), body weight, and age: p values, r values, and r 2 values

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

a, b, Scatter plots for correlation between body weight with silhouette length of wild-type animals: rats (a) and mice (b).

The correlation coefficients between the silhouette area (asil) and the CatWalk gait parameters are given in Table 4. The parameter scaling in Table 4 was performed based on the silhouette area. In rats, significant correlations (p < 0.05) with the silhouette area were shown for the gait parameters relating to stride length or speed, but not for the parameters relating to duration. All silhouette-area-based scaled gait parameters showed significant correlations with the silhouette area. In mice, most of the silhouette-area-scaled gait parameters gave lower p values compared with the nonscaled parameters. Some exceptions were revealed for the stand-time parameters, where both of the nonscaled and scaled gait parameters showed no significant correlation with the silhouette area.

View this table:
  • View inline
  • View popup
Table 4.

r and p values of the silhouette area (asil) and CatWalk gait parameters (scaling method: Embedded Image )

The correlation coefficients between w and the CatWalk gait parameters are given in Table 5. The scaling method in Table 5 was based on body weight. Both in rats and mice, significant correlations were found between the body weight and body-weight-scaled gait parameters.

View this table:
  • View inline
  • View popup
Table 5.

r and p values of w and CatWalk gait parameters (scaling method: Embedded Image )

The correlation coefficients and p values between age and the CatWalk gait parameters are given in Table 6. Significant correlations were found between the age and age-scaled gait parameters.

View this table:
  • View inline
  • View popup
Table 6.

r and p values of the age (a) and CatWalk gait parameters (scaling method: Embedded Image )

Genotype-related differences in silhouette-length-based scaled gait parameters in rodent models of neurodegenerative diseases

As a proof of concept for our scaling approach, we examined genotype-related differences for BAC α-Syn transgenic and BACHD animals as well as the effect of age and their interaction, as shown in Table 7. The mean and SEM of the silhouette lengths and several gait parameters are depicted in Figure 7. In addition, the p values of the multiple comparison tests are depicted by heat maps (Timotius et al., 2018a, 2019) in Figure 8. The color blue in the heat maps represents lower parameter value of the transgenic rodents compared with their corresponding wild type, whereas the color red in the heat maps represents the higher-parameter values of the transgenic rodents compared with their corresponding wild types.

View this table:
  • View inline
  • View popup
Table 7.

The effect of age, the genotype–age interaction and the effect of genotype on the silhouette parameters and gait parameters: mixed ANOVA and multiple-comparison tests with Bonferroni correction (p values with lower bound adjustment)

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

a–j, Genotype-related differences in unscaled and scaled hind stride length, unscaled and scaled hind swing speed, as well as silhouette length along with age: α-synuclein rat (a–e), BACHD mice (f–j). Each data point represents the mean ± SEM. p Values from multiple-comparison tests with Bonferroni correction: *p < 0.05, **p < 0.01, ***p < 0.001.

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Differences between wild-type and transgenic animal models observed by their unscaled and scaled gait parameters individually by multiple-comparison tests and reported in heat maps (Timotius et al., 2018a, 2019).

As shown in Table 7, all nonscaled gait parameters (stride lengths and speed-related gait parameters) and silhouette parameters showed significant effects of age (p < 0.05). In rats, the silhouette-length-based scaled gait parameters did not show any significant effect of age, whereas in mice, reduced age effects were observed in scaled gait parameters. No interaction between age and genotype in any gait parameter was observed. The genotype effects shown by the scaled gait parameters were lower compared with their corresponding nonscaled gait parameters. Besides the silhouette parameters, significant differences between genotypes were observed in scaled front stride length, scaled hind stride length, and scaled hind swing speed.

Significant genotype-related differences in the scaled front stride length were observed in 42-week-old rats. The scaled hind stride length showed significant differences between genotypes in the young rats until they were 42 weeks old. Furthermore, the scaled hind swing speed showed significant genotype-related differences for 10- and 26-week-old rats. In mice, significant differences of scaled gait parameters are shown only for scaled hind swing speed at 32 weeks of age.

Discussion

As in humans, several rodent gait parameters are correlated with body size. This study presents a body silhouette length computation method for rodents based on the recorded CatWalk videos. A correlational study was performed to investigate the relationship between the computed silhouette length and several CatWalk gait parameters. Accordingly, a silhouette-length-based scaling method on stride lengths and speed-related gait parameters is presented, which is able to reduce their correlation with body size. This silhouette-length-based scaling method cannot be directly replaced by silhouette-area-, body-weight-, or age-based scaling methods. As proof of concept, two rodent models of neurodegenerative disorders were investigated based on their scaled gait parameters. The results show smaller genotype-related differences compared with the nonscaled gait parameters due to the genotype-related body size difference.

The computed silhouette parameters, stride lengths, and speed-related gait parameters were found to change with advancing age. Significant effects of age on silhouette length and silhouette area, both with and without tail area, were observed in both rats and mice. Correlations between body silhouette length and stride lengths were significant for both rats and mice. The silhouette-length-based scaling/normalization reduced this correlation. The effect of age on stride lengths was significant in rats, but not in mice. However, in both species, the scaled parameters gave higher p values in the repeated-measures ANOVA compared with the nonscaled parameters. The effect of age on silhouette and gait parameters, as well as the effect of scaling on gait parameters, was more visible in rats compared with mice since the age range of the rats was broader than that of the mice. There was no significant effect of age on the scaled stride length. This suggests that the scaled stride lengths were better tools for a longitudinal study compared with the nonscaled stride lengths.

Significant correlations between silhouette length and speed (or velocity) parameters were observed in rats, but not in mice. Nevertheless, in rats and mice, both scaling methods gave scaled speed parameters with higher p values compared with the nonscaled version. The first scaling method, in accordance with Equation 7, was more suitable for the scaling of speed-related gait parameters. As speed is proportional to length and is inversely proportional to time, along with considering the nonsignificant correlation of duration-related gait parameter to the silhouette length, it is reasonable that the scaling method of the length-related gait parameters was also suitable for the speed-related gait parameters. Walking speed is a gait parameter that is affected by many factors (Batka et al., 2014). Therefore, it is reasonable that the correlations of silhouette length to the speed-related gait parameters were not as strong as the correlations to the length-related gait parameters.

No significant correlation was found in the gait parameters relating to duration. The silhouette length scaling on duration-related gait parameters produces scaled gait parameters, which are more correlated with silhouette length compared with the nonscaled version. This suggests that no silhouette-length-based scaling is needed for duration-related gait parameters.

In humans, gait parameters are typically evaluated by presenting data in the form of nondimensional numbers (Hof, 1996; Zijlstra et al., 1996). This scaling method suggested for human gait is not relevant to the practice in rodents. We recommend silhouette-length-based scaling in the stride lengths and speed parameters of rodents, but not in duration-related gait parameters since the duration-related gait parameters in rodents do not significantly correlate with silhouette-based body length.

The measured body lengths of anesthetized rats show significant correlation with the silhouette lengths. The measured body lengths were similar to the silhouette lengths with an absolute mean ± SD difference of 0.49 ± 0.39 cm. Most of the measured body lengths are higher compared with the silhouette length. This difference occurs most likely because of the different body curve while lying on a plain surface versus walking.

Since silhouette length, silhouette area, and body weight are all related to body size, they were all correlated to each other. However, replacing silhouette length with silhouette area for scaling is not recommended since the silhouette-area-based-scaled stride lengths and speed parameters were significantly correlated with the silhouette area. The same can be also noticed in the body-weight-based gait parameter scaling. The duration-related gait parameters did not display significant correlation with silhouette length or with body weight.

Although body size changes with the advancing age of the animal, silhouette-length-based gait parameter scaling should not be replaced by age-based parameter scaling. This is due to the fact that the age-based scaled gait parameters have significant correlations with age, which in all likelihood happened because the animals grow faster early in their lives (Lui and Baron, 2011). Therefore, age and body size do not have a linear correlation.

As rodents do not grow linearly (Lui and Baron, 2011), wild-type rats in our study grew over the months and reached the greatest silhouette length by the age of 10 months. Afterward, their silhouette length decreased slightly, possibly due to postural changes (hunched back). The wild-type mice showed an increase in silhouette length with advancing age.

In animal models with genotype-related body size differences, gait parameters can be directly and indirectly (through body size) related to the genotype. In the analysis of genotype-related differences as described in the section Genotype-related differences in silhouette-length-based scaled gait parameters in rodent models of neurodegenerative diseases, the effect of age was observed on all body parameters and nonscaled gait parameters. The genotype and age of the animals had lower effects on the scaled gait parameters compared with the nonscaled gait parameters for rodent models with genotype-related body size differences. No significant genotype–age interaction was observed. Considering the results shown in Figures 7 and 8, significant genotype-driven silhouette length differences were observed. Additionally, fewer genotype-related gait parameter differences were detected by the scaled gait parameters. Gait analysis in preclinical studies is mostly aimed at the development of new treatment strategies for specific diseases. Observing the effects of diseases and treatments on gait is often more important than observing the effect of body size on gait. Therefore, gait parameters used in the analysis of gait should have a minimal relation to body size. Accordingly, the results in Figures 7 and 8 yield an analytic value improvement, as the scaling/normalizing approach reduces the effect of body size. Therefore, it can be confirmed that gait parameter scaling is recommended in a study involving rodent models with significant genotype-related silhouette length differences.

Significant genotype-related differences in the α-synuclein rat model was detected on scaled stride lengths, scaled hind-paw swing speed, silhouette length, silhouette area, and body weight. By observing the silhouette length, area, and body weight, the α-synuclein rats were smaller compared with their wild-type littermates. Genotype-related differences in the α-synuclein rat model were more pronounced in young animals than in geriatric animals.

In the BACHD mouse model, a genotype-related difference was observed on scaled hind-paw swing speed, specifically in 32-week-old mice. The body parameters show that the BACHD mice are bigger compared with their wild-type littermates.

Further possible applications of the line representing the silhouette length are in the development of a 2D Eshkol Wachmann Notation (Eilam and Golani, 1988) and body coordinate frame (Neckel, 2015). As body silhouettes provided by the CatWalk system are the projection of the body of the rodent, body silhouette length is not the same as body length. A further comparison study based on body length (mouth–anus) could offer insight into its usage for gait parameter scaling, despite the fact that anesthesia would be needed. Since body weight is correlated with print dimensions (print length, width, and area; Zimprich et al., 2018), a further study on print dimension parameters scaling by body weight is recommended. Furthermore, a correlation study between the print position (distance between the position of the hindpaw and the position of the previously placed front paw on the same side of the body) and body size might also be valuable for gait analysis in rodents. Moreover, a similar study on the relation between body size and treadmill-based gait parameters (Sparrow et al., 2017) will be valuable for the field of preclinical gait analysis.

In summary, a method of calculating body silhouette length is described in this article. This silhouette length is beneficial for the scaling of stride length and speed-related gait parameters. Gait parameter scaling is suggested to be an important tool for augmenting the reliability of motor function analyses in rodent models, especially in studies involving young animals and/or rodent models with genotype-related silhouette length differences, as well as in longitudinal studies.

Acknowledgments

Acknowledgments: We thank Silke Nuber for help in transferring the rodent models from Tübingen to the study site in Erlangen at the Preclinical Experimental Animal Center.

Footnotes

  • The authors declare no competing financial interests.

  • I.K.T. received financial support from DAAD for research studies (Research Grant 57129429). S.M., A.-C.P., J.H., F.C. and S.v.H., were supported by the EU Joint Programme-Neurodegenerative Disease Research (JPND) project CrossSeeds (Grant 01ED1501C). J.W. and J.K. were supported by the Interdisciplinary Center of Clinical Research (IZKF; Grants E21 and E11) of the University Hospital Erlangen, Germany, and the Bavarian State Ministry of Education and Culture, Science and Arts in the framework of the Bavarian Research Network for Induced Pluripotent Stem Cells (ForIPS) and the European Institute of Innovation and Technology Health (EIT Health; MoveIT). J.K. was supported by the Deutsche Forschungsgemeinschaft (DFG; Grant KL1395/8-1). N.C. and O.R. were supported by NEURASYNC: an Academic Industrial Initial Training Network (ITN) through the people program FP7 of the European Union and FCT (Grant PTDC/SAU-NEU/105215/2008). B.E. was supported by the DFG within the framework of the Heisenberg Professorship program (Grant ES 434/8-1). S.M., F.C., and S.v.H. acknowledge the support by the JPND project CrossSeeds (Grant 01ED1501C). This research was supported by the DFG and Friedrich-Alexander-Universität Erlangen-Nürnberg within the funding program Open Access Publishing.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Batka RJ, Brown TJ, Mcmillan KP, Meadows RM, Jones KJ, Haulcomb MM (2014) The need for speed in rodent locomotion analyses. Anat Rec 297:1839–1864. doi:10.1002/ar.22955 pmid:24890845
    OpenUrlCrossRefPubMed
  2. ↵
    Cao Y, Shumsky JS, Sabol MA, Kushner RA, Strittmatter S, Hamers FPT, Lee DHS, Rabacchi SA, Murray M (2008) Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil Neural Repair 22:262–278. doi:10.1177/1545968307308550 pmid:18056009
    OpenUrlCrossRefPubMed
  3. ↵
    Casadei N, Pöhler A-M, Tomás-Zapico C, Torres-Peraza J, Schwedhelm I, Witz A, Zamolo I, De Heer R, Spruijt B, Noldus L, Klucken J, Lucas JJ, Kahle PJ, Krüger R, Riess O, Nuber S (2014) Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice. Hum Mol Genet 23:767–781. doi:10.1093/hmg/ddt467 pmid:24064336
    OpenUrlCrossRefPubMed
  4. ↵
    Chakraborty R, Park HN, Tan CC, Weiss P, Prunt MC, Pardue MT (2017) Association of body length with ocular parameters in mice. Optom Vis Sci 94:387–394. doi:10.1097/OPX.0000000000001036 pmid:28005683
    OpenUrlCrossRefPubMed
  5. ↵
    Chen Y-J, Cheng F-C, Sheu M-L, Su H-L, Chen C-J, Sheehan J, Pan H-C (2014) Detection of subtle neurological alterations by the Catwalk XT gait analysis system. J Neuroeng Rehabil 11:62.
    OpenUrl
  6. ↵
    Clemensson EKH, Clemensson LE, Fabry B, Riess O, Nguyen HP (2017) Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease. PLoS One 12:e0173232. doi:10.1371/journal.pone.0173232 pmid:28273120
    OpenUrlCrossRefPubMed
  7. ↵
    Datto JP, Shah AK, Bastidas JC, Arheart KL, Marcillo AE, Dietrich WD, Pearse DD (2016) Use of the CatWalk gait device to assess differences in locomotion between genders in rats inherently and following spinal cord injury. Dataset Pap Sci 2016:1–11. doi:10.1155/2016/6276348
    OpenUrlCrossRef
  8. ↵
    Dunn GA, Bale TL (2009) Maternal high-fat diet promotes body length increases and insulin insensitivity in second-generation mice. Endocrinology 150:4999–5009. doi:10.1210/en.2009-0500 pmid:19819967
    OpenUrlCrossRefPubMed
  9. ↵
    Eilam D, Golani I (1988) The ontogeny of exploratory behavior in the house rat (Rattus rattus): the mobility gradient. Dev Psychobiol 21:679–710. doi:10.1002/dev.420210707 pmid:3234601
    OpenUrlCrossRefPubMed
  10. ↵
    Frahm S, Melis V, Horsley D, Rickard JE, Riedel G, Fadda P, Scherma M, Harrington CR, Wischik CM, Theuring F, Schwab K (2018) Alpha-synuclein transgenic mice, h-α-synL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson’s disease. Behav Brain Res 339:153–168. doi:10.1016/j.bbr.2017.11.025 pmid:29180135
    OpenUrlCrossRefPubMed
  11. ↵
    Gonzalez RC, Woods RE (2008) Digital image processing, Ed 3. Upper Saddle River, NJ: Prentice-Hall.
  12. ↵
    Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, Lu X-H, Tao J, Yamazaki I, Li S-H, Sun YE, Li X-J, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD Mice. J Neurosci 28:6182–6195. doi:10.1523/JNEUROSCI.0857-08.2008 pmid:18550760
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Hamers FPT, Lankhorst AJ, Jan T, Laar V, Veldhuis WB, Gispen WH (2001) Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma 18:187–201. doi:10.1089/08977150150502613 pmid:11229711
    OpenUrlCrossRefPubMed
  14. ↵
    Hamers FPT, Koopmans GC, Joosten EAJ (2006) CatWalk-assisted gait analysis in the assessment of spinal cord injury. J Neurotrauma 23:537–548. doi:10.1089/neu.2006.23.537 pmid:16629635
    OpenUrlCrossRefPubMed
  15. ↵
    Heglund NC, Taylor RC, McMahon TA (1974) Scaling stride frequency and gait to animal size: mice to horses. Science 186:1112–1113. doi:10.1126/science.186.4169.1112 pmid:4469699
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Hof AL (1996) Scaling gait data to body size. Gait Posture 4:222–223. doi:10.1016/0966-6362(95)01057-2
    OpenUrlCrossRef
  17. ↵
    Ishikawa G, Nagakura Y, Takeshita N, Shimizu Y (2014) Efficacy of drugs with different mechanisms of action in relieving spontaneous pain at rest and during movement in a rat model of osteoarthritis. Eur J Pharmacol 738:111–117. doi:10.1016/j.ejphar.2014.05.048 pmid:24939049
    OpenUrlCrossRefPubMed
  18. ↵
    Jacobs BY, Kloefkorn HE, Allen KD (2014) Gait analysis methods for rodent models of osteoarthritis. Curr Pain Headache Rep 18:456. doi:10.1007/s11916-014-0456-x pmid:25160712
    OpenUrlCrossRefPubMed
  19. ↵
    Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376. doi:10.1136/jnnp.2007.131045 pmid:18344392
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Karwacki Z, Kowiański P, Moryś J (2001) General anaesthesia in rats undergoing experiments on the central nervous system. Folia Morphol (Warsz) 60:235–242. pmid:11770333
    OpenUrlPubMed
  21. ↵
    Kohl Z, Abdallah NB, Vogelgsang J, Tischer L, Deusser J, Amato D, Anderson S, Müller CP, Riess O, Masliah E, Nuber S, Winkler J (2016) Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson’s disease. Neurobiol Dis 85:206–217. doi:10.1016/j.nbd.2015.10.021 pmid:26523794
    OpenUrlCrossRefPubMed
  22. ↵
    Koopmans GC, Deumens R, Brook G, Gerver J, Honig WMM, Hamers FPT, Joosten EAJ (2007) Strain and locomotor speed affect over-ground locomotion in intact rats. Physiol Behav 92:993–1001. doi:10.1016/j.physbeh.2007.07.018 pmid:17959205
    OpenUrlCrossRefPubMed
  23. ↵
    Lui JC, Baron J (2011) Mechanisms limiting body growth in mammals. Endocr Rev 32:422–440. doi:10.1210/er.2011-0001 pmid:21441345
    OpenUrlCrossRefPubMed
  24. ↵
    Machado AS, Darmohray DM, Fayad J, Marques HG, Carey MR (2015) A quantitative framework for whole-body coordination reveals specific deficits in freely walking ataxic mice. Elife 4:e07892. doi:10.7554/eLife.07892
    OpenUrlCrossRefPubMed
  25. ↵
    Moceri S, Canneva F, Habermeyer J, Dobner J, Schulze-Krebs A, Puchades M, Bjaalie JG, Kohl Z, Winkler J, Timotius IK, Eskofier B, Schilling S, Demuth H, Hartlage-Rübsamen M, Rossner S, Casadei N, Riess O, von Hörsten S (2018) Association of early phenotypic behavioral alterations in human α-synuclein overexpressing transgenic rats with α-synuclein/huntingtin/amyloid-β protein cross-seeding. Paper presented at AAT-AD/PD Focus Meeting 2018, Torino, Italy, March.
  26. ↵
    Neckel ND (2015) Methods to quantify the velocity dependence of common gait measurements from automated rodent gait analysis devices. J Neurosci Methods 253:244–253. doi:10.1016/j.jneumeth.2015.06.017 pmid:26129742
    OpenUrlCrossRefPubMed
  27. ↵
    Neckel ND, Dai H, Bregman BS (2013) Quantifying changes following spinal cord injury with velocity dependent locomotor measures. J Neurosci Methods 214:27–36. doi:10.1016/j.jneumeth.2013.01.008 pmid:23333791
    OpenUrlCrossRefPubMed
  28. ↵
    Noldus Information Technology b.v. (2012) CatWalk XT version 10.0. reference manual. Wageningen, The Netherlands: Noldus Information Technology b.v.
  29. ↵
    Novelli ELB, Diniz YS, Galhardi CM, Ebaid GMX, Rodrigues HG, Mani F, Fernandes AAH, Cicogna AC, Novelli Filho J (2007) Anthropometrical parameters and markers of obesity in rats. Lab Anim 41:111–119. doi:10.1258/002367707779399518 pmid:17234057
    OpenUrlCrossRefPubMed
  30. ↵
    Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Schönig K, Zimmermann F, Bauer C, Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, Müller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J, et al. (2013) A progressive dopaminergic phenotype associated with neurotoxic conversion of a-synuclein in BAC-transgenic rats. Brain 136:412–432. doi:10.1093/brain/aws358 pmid:23413261
    OpenUrlCrossRefPubMed
  31. ↵
    Pearson K (1895) Note on regression and inheritance in the case of two parents. Proc R Soc Lond 58:240–242.
    OpenUrlCrossRef
  32. ↵
    Roos RA (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5:40. doi:10.1186/1750-1172-5-40 pmid:21171977
    OpenUrlCrossRefPubMed
  33. ↵
    Salvi J, Bertaso F, Mausset-Bonnefont A-L, Metz A, Lemmers C, Ango F, Fagni L, Lory P, Mezghrani A (2014) RNAi silencing of P/Q-type calcium channels in Purkinje neurons of adult mouse leads to episodic ataxia type 2. Neurobiol Dis 68:47–56. doi:10.1016/j.nbd.2014.04.005 pmid:24768804
    OpenUrlCrossRefPubMed
  34. ↵
    Sparrow LM, Pellatt E, Yu SS, Raichlen DA, Pontzer H, Rolian C (2017) Gait changes in a line of mice artificially selected for longer limbs. PeerJ 5:e3008. doi:10.7717/peerj.3008
    OpenUrlCrossRef
  35. ↵
    Taylor CR (1978) Why change gaits? Recruitment of muscles and muscle fibers as a function of speed and gait. Am Zool 18:153–161.
    OpenUrlCrossRef
  36. ↵
    Timotius IK, Canneva F, Minakaki G, Moceri S, Casadei N, Riess O, Winkler J, von Hörsten S, Eskofier B, Klucken J (2018a) Systematic data analysis and data mining in gait analysis by heat mapping. In: Measuring behavior 2018 conference proceedings ( Grant RA, Allen T, Spink A, Sullivan M , eds), pp 43–49. Manchester, U.K.: Manchester Metropolitan University.
  37. ↵
    Timotius IK, Canneva F, Minakaki G, Pasluosta C, Moceri S, Casadei N, Riess O, Winkler J, Klucken J, von Hörsten S, Eskofier B (2018b) Dynamic footprint based locomotion sway assessment in α-synucleinopathic mice using fast Fourier transform and low pass filter. J Neurosci Methods 296:1–11. doi:10.1016/j.jneumeth.2017.12.004 pmid:29253577
    OpenUrlCrossRefPubMed
  38. ↵
    Timotius IK, Canneva F, Minakaki G, Pasluosta C, Moceri S, Casadei N, Riess O, Winkler J, Klucken J, von Hörsten S, Eskofier B (2018c) Dynamic footprints of α-synucleinopathic mice recorded by CatWalk gait analysis. Data Brief 17:189–193. doi:10.1016/j.dib.2017.12.067 pmid:29876385
    OpenUrlCrossRefPubMed
  39. ↵
    Timotius IK, Moceri S, Plank AC, Habermeyer J, Canneva F, Casadei N, Riess O, Winkler J, Klucken J, Eskofier B, von Hörsten S (2018d) Rodent’s stride length depends on body size: implications for CatWalk assay. In: Measuring behavior 2018 conference proceedings ( Grant RA, Allen T, Spink A, Sullivan M , eds), pp 50–52. Manchester, U.K.: Manchester Metropolitan University.
  40. ↵
    Timotius IK, Canneva F, Minakaki G, Moceri S, Plank A-C, Casadei N, Riess O, Winkler J, Klucken J, Eskofier B, von Hörsten S (2019) Systematic data analysis and data mining in CatWalk gait analysis by heat mapping exemplified in rodent models for neurodegenerative diseases. J Neurosci Methods 326:108367.
    OpenUrl
  41. ↵
    Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson’s disease. Lancet Neurol 5:75–86. doi:10.1016/S1474-4422(05)70285-4 pmid:16361025
    OpenUrlCrossRefPubMed
  42. ↵
    Vandeputte C, Taymans J-M, Casteels C, Coun F, Ni Y, van Laere K, Baekelandt V (2010) Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci 11:92. doi:10.1186/1471-2202-11-92 pmid:20691122
    OpenUrlCrossRefPubMed
  43. ↵
    von Hörsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, Grasshoff U, Bauer I, Vieira-Saecker AM, Paul M, Jones L, et al. (2003) Transgenic rat model of Huntington’s disease. Hum Mol Genet 12:617–624. doi:10.1093/hmg/ddg075 pmid:12620967
    OpenUrlCrossRefPubMed
  44. ↵
    Wang XH, Lu G, Hu X, Tsang KS, Kwong WH, Wu FX, Meng HW, Jiang S, Liu SW, Ng HK, Poon WS (2012) Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease. BMC Neurosci 13:142. doi:10.1186/1471-2202-13-142 pmid:23151254
    OpenUrlCrossRefPubMed
  45. ↵
    Webb AA, Gowribai K, Muir GD (2003) Fischer (F-344) rats have different morphology, sensorimotor and locomotor abilities compared to Lewis, Long-Evans, Sprague-Dawley and Wistar rats. Behav Brain Res 144:143–156. doi:10.1016/s0166-4328(03)00076-7 pmid:12946605
    OpenUrlCrossRefPubMed
  46. ↵
    Zijlstra W, Prokop T, Berger W (1996) Adaptability of leg movements during treadmill walking and split-belt walking in children. Gait Posture 4:212–221. doi:10.1016/0966-6362(95)01065-3
    OpenUrlCrossRef
  47. ↵
    Zimprich A, Östereicher MA, Becker L, Dirscherl P, Ernst L, Fuchs H, Gailus-Durner V, Garrett L, Giesert F, Glasl L, Hummel A, Rozman J, de Angelis MH, Vogt-Weisenhorn D, Wurst W, Hölter SM (2018) Analysis of locomotor behavior in the German mouse clinic. J Neurosci Methods 300:77–91. doi:10.1016/j.jneumeth.2017.05.005 pmid:28483715
    OpenUrlCrossRefPubMed

Synthesis

Reviewing Editor: Tatyana Sharpee, The Salk Institute for Biological Studies

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: NONE.

In the manuscript titled “Silhouette-length-scaled gait parameters for motor functional analysis in mice and rats,” the authors attempt to address the issue that variation in body size can confound automated gait tracking analysis. Using silhouette-derived body length parameters, as well as silhouette area, body weight, and age, they test which scaling approaches most appropriately dissociate kinematic parameters from body size, finding that normalizing for silhouette length produces the best decorrelation. They then apply this approach to analysis of rodent motor disease models, demonstrating that genotype-related differences in body size affect the assessment of locomotor kinematics, including stride length, body speed, and swing speed.

Overall, this manuscript provides convincing evidence that scaling for silhouette length reduces correlations with body size that can affect kinematic analysis. Moreover, that fact that silhouette length can be measured from the same locomotion dataset (rather than through independent measurement in anesthetized rodents, for example) provides a convenient and efficient way to achieve the scaling they describe. That said, some major assumptions are made that need to be explained and justified a bit more clearly.

1. It seems that the major goal of this manuscript is to achieve a more reliable measure of the direct relationship between genotype-to-gait (direct effect), without the potential confound of an indirect relationship between genotype-to-body size-to-gait (indirect effect). It would be helpful if the authors explicitly describe this framework of direct and indirect causality and how they both affect gait. There is an assumption that the direct and indirect effects are completely independent, and normalizing one will not affect the other. Why does genotype influence on gait through body size (indirect effect) inherently confound gait analysis? It does seem like a reasonable goal to dissociate direct and indirect effects of genotype on gait, but this goal and the assumptions behind it were never clearly described or justified.

An example of an assumption that needs to be more clearly explained is that the indirect effect of genotype on gait (through body length) has multiplicative confounding effects, and therefore dividing body length out of the gait parameters removes the confound. Again, this might be correct, but the logical arguments behind their assumptions are never explained.

Another example is that on lines 405-408, the authors recommend normalizing only those gait parameters that exhibit a significant correlation with silhouette length. This argument lacks a convincing explanation. It seems that the authors argue that if something is correlated with body length, it is inherently confounding. While this might be a reasonable assumption, the authors should discuss their causal logic more explicitly, including any caveats to their assumptions.

2. The manuscript lacks comparison with physical measurements (ground truth) to validate their technology. It would be nice to see some physical confirmation of the computed silhouette length (i.e. take a physical measurement of body length on a subset of anesthetized animals and compare to the computed values).

Minor point: check for awkward wording and typos throughout- e.g. line 90 “as very often desirable”, line 715 “of a function with age”, etc.

Author Response

The authors of the manuscript eNeuro eN-MNT-0100-19 entitled “Silhouette-length-scaled gait parameters for motor functional analysis in mice and rats” would like to thank the reviewers for the valuable and insightful comments for the manuscript. The present version of our manuscript has been carefully revised following the comments in every regard. All changes are marked in our revised manuscript. A point-by-point reply to all specific issues and comments follows.

Computational Neuroscience Model Code Accessibility Comments for Author (Required):

There is no separate “code accessibility” section but the data collection procedure was clearly described. The authors used the Catwalk system for markerless gait analysis (Hamers et al., 2006, 136 2001; Noldus Information Technology b.v., 2012).

Response:

Code accessibility section is added to the manuscript (Section 2.5).

Significance Statement Comments for Author (Required):

The statement is well written

Response:

-

Comments on the Visual Abstract for Author (Required):

The abstract is informative and conveys the major conclusion

Response:

-

Synthesis Statement for Author (Required):

In the manuscript titled “Silhouette-length-scaled gait parameters for motor functional analysis in mice and rats,” the authors attempt to address the issue that variation in body size can confound automated gait tracking analysis. Using silhouette-derived body length parameters, as well as silhouette area, body weight, and age, they test which scaling approaches most appropriately dissociate kinematic parameters from body size, finding that normalizing for silhouette length produces the best decorrelation. They then apply this approach to analysis of rodent motor disease models, demonstrating that genotype-related differences in body size affect the assessment of locomotor kinematics, including stride length, body speed, and swing speed.

Overall, this manuscript provides convincing evidence that scaling for silhouette length reduces correlations with body size that can affect kinematic analysis. Moreover, that fact that silhouette length can be measured from the same locomotion dataset (rather than through independent measurement in anesthetized rodents, for example) provides a convenient and efficient way to achieve the scaling they describe. That said, some major assumptions are made that need to be explained and justified a bit more clearly.

Point 1a:

1. It seems that the major goal of this manuscript is to achieve a more reliable measure of the direct relationship between genotype-to-gait (direct effect), without the potential confound of an indirect relationship between genotype-to-body size-to-gait (indirect effect). It would be helpful if the authors explicitly describe this framework of direct and indirect causality and how they both affect gait. There is an assumption that the direct and indirect effects are completely independent, and normalizing one will not affect the other. Why does genotype influence on gait through body size (indirect effect) inherently confound gait analysis? It does seem like a reasonable goal to dissociate direct and indirect effects of genotype on gait, but this goal and the assumptions behind it were never clearly described or justified.

Response:

The description of the framework of direct (genotype-to-gait) and indirect (genotype-to-body_size-to-gait) causality was added in Section 4 Paragraph 9.

Normalizing the body_size-to-gait effect will reduce the effect of genotype-to-body_size-to-gait, which makes it possible for researchers to focus more on the genotype-to-gait effect.

Gait analysis in preclinical studies is mostly aimed at the development of new treatment strategies for specific diseases. Observing the effect of diseases and treatments on gait is often more important than observing the effect of body size on gait. Therefore, gait parameters used in the analysis of gait should have minimal relation with body size. This goal was added in Section 4 Paragraph 9.

Point 1b:

An example of an assumption that needs to be more clearly explained is that the indirect effect of genotype on gait (through body length) has multiplicative confounding effects, and therefore dividing body length out of the gait parameters removes the confound. Again, this might be correct, but the logical arguments behind their assumptions are never explained.

Response:

We would like to acknowledge the reviewers for pointing out the inequality between correlation and causality. We agree with the reviewers that we should not assume: correlation always imply direct causality. The manuscript is therefore revised to the direction of correlation study, as here (described in Section 3.1) we present that: several gait parameters are related with body length and dividing it with the body length can reduce the relationship.

Point 1c:

Another example is that on lines 405-408, the authors recommend normalizing only those gait parameters that exhibit a significant correlation with silhouette length. This argument lacks a convincing explanation. It seems that the authors argue that if something is correlated with body length, it is inherently confounding. While this might be a reasonable assumption, the authors should discuss their causal logic more explicitly, including any caveats to their assumptions.

Response:

We would like to again thanks the reviewers for pointing out that correlation do not imply causality. The description of causality and how body-size affect gait in rodents will need an elaboration of body mechanism and muscle activity, in which a broader study design is needed. Therefore, we revised the manuscript emphasizing more to the correlation/relation between gait parameters and body size.

Point 2:

2. The manuscript lacks comparison with physical measurements (ground truth) to validate their technology. It would be nice to see some physical confirmation of the computed silhouette length (i.e. take a physical measurement of body length on a subset of anesthetized animals and compare to the computed values).

Response:

Additional study comparing silhouette length and body length based on physical measurement is presented in Section 3.1.

Point 3:

Minor point: check for awkward wording and typos throughout- e.g. line 90 “as very often desirable”, line 715 “of a function with age”, etc.

Response:

Thank you for pointing this out. The sentences has been changed.

Back to top

In this issue

eneuro: 6 (6)
eNeuro
Vol. 6, Issue 6
November/December 2019
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Silhouette-Length-Scaled Gait Parameters for Motor Functional Analysis in Mice and Rats
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Silhouette-Length-Scaled Gait Parameters for Motor Functional Analysis in Mice and Rats
Ivanna K. Timotius, Sandra Moceri, Anne-Christine Plank, Johanna Habermeyer, Fabio Canneva, Jürgen Winkler, Jochen Klucken, Nicolas Casadei, Olaf Riess, Bjoern Eskofier, Stephan von Hörsten
eNeuro 11 October 2019, 6 (6) ENEURO.0100-19.2019; DOI: 10.1523/ENEURO.0100-19.2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Silhouette-Length-Scaled Gait Parameters for Motor Functional Analysis in Mice and Rats
Ivanna K. Timotius, Sandra Moceri, Anne-Christine Plank, Johanna Habermeyer, Fabio Canneva, Jürgen Winkler, Jochen Klucken, Nicolas Casadei, Olaf Riess, Bjoern Eskofier, Stephan von Hörsten
eNeuro 11 October 2019, 6 (6) ENEURO.0100-19.2019; DOI: 10.1523/ENEURO.0100-19.2019
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • CatWalk
  • gait
  • Huntington
  • normalization
  • Parkinson
  • scaling

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Methods/New Tools

  • Superficial Bound of the Depth Limit of Two-Photon Imaging in Mouse Brain
  • A Toolbox of Criteria for Distinguishing Cajal–Retzius Cells from Other Neuronal Types in the Postnatal Mouse Hippocampus
  • Assessment of Spontaneous Neuronal Activity In Vitro Using Multi-Well Multi-Electrode Arrays: Implications for Assay Development
Show more Methods/New Tools

Novel Tools and Methods

  • Superficial Bound of the Depth Limit of Two-Photon Imaging in Mouse Brain
  • A Toolbox of Criteria for Distinguishing Cajal–Retzius Cells from Other Neuronal Types in the Postnatal Mouse Hippocampus
  • Assessment of Spontaneous Neuronal Activity In Vitro Using Multi-Well Multi-Electrode Arrays: Implications for Assay Development
Show more Novel Tools and Methods

Subjects

  • Novel Tools and Methods

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.